Literature DB >> 15642277

Repeated immunization induces the increase in fucose content on antigen-specific IgG N-linked oligosaccharides.

Naxin Guo1, Yang Liu, Yutaka Masuda, Masami Kawagoe, Yasuharu Ueno, Takashi Kameda, Toshihiro Sugiyama.   

Abstract

OBJECTIVE: In order to investigate whether repeated immunization induces changes in IgG glycosylation, we analyzed the composition of oligosaccharides on antigen-specific IgGs obtained from mice that received different amounts of immunization boosts.
METHODS: Three groups of mice were immunized with ovalbumin (OVA) and boosted once, twice, or three times, respectively, with an interval of 1 week. The patterns of oligosaccharides present in anti-OVA specific IgGs were analyzed using lectin-enzyme-linked immunosorbent assay (ELISA) and lectin-blot.
RESULTS: The repeated injection of OVA induced both the production of specific IgGs and an increase of fucose content in N-linked oligosaccharides of the IgGs. The lowest IgG fucosylation was observed in mice boosted once, whereas the highest fucosylation rate was observed in mice boosted three times. ELISA assay demonstrated that there was a positive relationship between the fucose content and amount of immunization boosts.
CONCLUSIONS: IgG fucosylation increases during repeated immunization with ovalbumin. The alteration of IgG fucosylation may have important biological significance.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15642277     DOI: 10.1016/j.clinbiochem.2004.10.002

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  13 in total

1.  The history of IgG glycosylation and where we are now.

Authors:  Brian A Cobb
Journal:  Glycobiology       Date:  2020-03-20       Impact factor: 4.313

2.  N-glycosylation regulates ADAM8 processing and activation.

Authors:  Srimathi Srinivasan; Mathilde Romagnoli; Andrew Bohm; Gail E Sonenshein
Journal:  J Biol Chem       Date:  2014-10-21       Impact factor: 5.157

3.  Microscale purification of antigen-specific antibodies.

Authors:  Eric P Brown; Erica Normandin; Nana Yaw Osei-Owusu; Alison E Mahan; Ying N Chan; Jennifer I Lai; Monica Vaccari; Mangala Rao; Genoveffa Franchini; Galit Alter; Margaret E Ackerman
Journal:  J Immunol Methods       Date:  2015-06-12       Impact factor: 2.303

Review 4.  With or without sugar? (A)glycosylation of therapeutic antibodies.

Authors:  Dmitrij Hristodorov; Rainer Fischer; Lars Linden
Journal:  Mol Biotechnol       Date:  2013-07       Impact factor: 2.695

5.  Conference report: "Functional Glycomics in HIV Type 1 Vaccine Design" workshop report, Bethesda, Maryland, April 30-May 1, 2012.

Authors:  Angela Malaspina; Brenda S Collins; Anne Dell; Galit Alter; Thandi M Onami
Journal:  AIDS Res Hum Retroviruses       Date:  2013-07-19       Impact factor: 2.205

6.  Aleuria Aurantia Lectin (AAL)-reactive immunoglobulin G rapidly appears in sera of animals following antigen exposure.

Authors:  Songming Chen; Chen Lu; Hongbo Gu; Anand Mehta; Jianwei Li; Patrick B Romano; David Horn; D Craig Hooper; Carthene R Bazemore-Walker; Timothy Block
Journal:  PLoS One       Date:  2012-09-14       Impact factor: 3.240

7.  Antibody-Mediated Fcγ Receptor-Based Mechanisms of HIV Inhibition: Recent Findings and New Vaccination Strategies.

Authors:  Vincent Holl; Maryse Peressin; Christiane Moog
Journal:  Viruses       Date:  2009-12-15       Impact factor: 5.048

8.  Changes in antigen-specific IgG1 Fc N-glycosylation upon influenza and tetanus vaccination.

Authors:  Maurice H J Selman; Sanne E de Jong; Darius Soonawala; Frank P Kroon; Ayola Akim Adegnika; André M Deelder; Cornelis H Hokke; Maria Yazdanbakhsh; Manfred Wuhrer
Journal:  Mol Cell Proteomics       Date:  2011-12-19       Impact factor: 5.911

9.  A pilot study showing differences in glycosylation patterns of IgG subclasses induced by pneumococcal, meningococcal, and two types of influenza vaccines.

Authors:  Anne Cathrine Vestrheim; Anders Moen; Wolfgang Egge-Jacobsen; Leon Reubsaet; Trine Grønhaug Halvorsen; Diane Bryant Bratlie; Berit Smestad Paulsen; Terje Einar Michaelsen
Journal:  Immun Inflamm Dis       Date:  2014-05-22

Review 10.  Sialylated Immunoglobulins for the Treatment of Immuno-Inflammatory Diseases.

Authors:  Yuliya V Markina; Elena V Gerasimova; Alexander M Markin; Victor Y Glanz; Wei-Kai Wu; Igor A Sobenin; Alexander N Orekhov
Journal:  Int J Mol Sci       Date:  2020-07-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.